Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Werner Stransky is active.

Publication


Featured researches published by Werner Stransky.


Journal of Neurochemistry | 2002

Preincubation with Creatine Enhances Levels of Creatine Phosphate and Prevents Anoxic Damage in Rat Hippocampal Slices

Adrian Carter; R.Enzio Müller; Uwe Pschorn; Werner Stransky

Abstract: We have investigated the relationship between energy metabolism, NMDA‐receptor antagonism, and anoxic damage in vitro. Anoxic damage was assessed by measuring protein synthesis, defined as the incorporation of [14C]lysine into perchloric acid‐insoluble tissue extracts. The concentrations of energy metabolites were measured by ion‐exchange HPLC. Anoxia caused an inhibition of protein synthesis, a reduction in phosphocreatine and adenosine triphosphate, and extensive neuronal damage. The reduction of protein synthesis depended on the duration of anoxia and the time allowed for recovery. Preincubation with the creatine dose‐dependently (0.03–3 mmol/L) increased baseline levels of phosphocreatine, reduced the anoxia‐induced decline in phosphocreatine and adenosine triphosphate, prevented the impairment of protein synthesis, and reduced neuronal death. Incubation with (R,S)‐3‐guanidinobutyric acid, a synthetic analogue of creatine that cannot be phosphorylated, did not prevent the anoxia‐induced impairment of protein synthesis and did not enhance the levels of phosphocreatine and adenosine triphosphate. Incubation with a combination of both creatine and the noncompetitive NMDA antagonist MK‐801 provided complete protection. These results indicate that energy status is a major factor controlling anoxic damage in the rat hippocampal slice.


Archive | 1989

Xanthin derivatives having an adenosin-antagonist activity

Ulrike Küfner-Mühl; Karl-Heinz Weber; Gerhard Walther; Werner Stransky; Helmut Dipl Chem Dr Ensinger; Gunter Schingnitz; Franz Josef Kuhn; Erich Lehr


Archive | 1994

8-substituted 1,3-dialiphaticxanthine derivatives

Ulrike Küfner-Mühl; Werner Stransky; Gerhard Walther; Karl-Heinz Weber; Helmut Ensinger; Franz Josef Kuhn; Gunter Schingnitz; Erich Lehr


Archive | 1991

New xanthine derivatives

Ulrike Küfner-Mühl; Werner Stransky; Karl-Heinz Weber; Helmut Ensinger; Franz Josef Kuhn; Gunter Schingnitz; Erich Lehr; Gerhard +Di Walther


Archive | 1995

Quinuclidines, their use as medicaments and processes for their preparation

Gerhard Walther; Karl-Heinz Weber; Werner Stransky; Franz Dr. Kuhn; Enzio Muller; Helmut Dipl Chem Dr Ensinger


Archive | 1987

Thieno-1,4-diazepines

Werner Stransky; Karl-Heinz Weber; Gerhard Walther; Albrecht Harreus; Stenzel Jorge Casals; Gojko Muacevic; Wolf-Dietrich Bechtel


Archive | 1989

Quinuclidines, their pharmaceutical use and process for their preparation

Gerhard Walther; Karl-Heinz Weber; Werner Stransky; Franz Dr. Kuhn; Enzio Muller; Helmut Dipl Chem Dr Ensinger


Archive | 1991

Bicyclic 1-azacycloalcanes.

Gerhard Walther; Ulrike Küfner-Mühl; Werner Stransky; Karl-Heinz Weber; Helmut Ensinger; Franz Josef Kuhn; Enzio Muller


Archive | 1995

Useful for treating neurodegenerative diseases

Herbert Merz; Enzio Mueller; Werner Stransky; Ilse Streller


Archive | 1987

Novel hetrazepines and process for their preparation

Karl-Heinz Weber; Albrecht Harreus; Werner Stransky; Gerhard Walther; Stenzel Jorge Casals; Gojko Muacevic; Hubert Dr. Heuer; Wolf-Dietrich Bechtel

Collaboration


Dive into the Werner Stransky's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge